Biogen Overview
Biogen Target Price
Analysts' 12-month price predictions for BIIB.
Share Price
$139.94
Average Target Price
$200.00
42.9% upside
42.9% upside2 analysts in the last 4 months
High: $213 | Low: $187
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-06-25 | RBC CapitalBrian Abrahams | $213 | 52.2% upside |  |
| 2025-05-05 | H.C. WainwrightAndrew Fein | $187 | 33.6% upside | |
| 2025-05-02 | OppenheimerJay Olson | $205 | 46.5% upside | |
| 2025-04-28 | HSBC | $118 |  15.7% downside | |
| 2025-02-13 | Canaccord GenuitySumant Kulkarni | $265 | 89.4% upside | |
| 2025-02-12 | Wells FargoMohit Bansal | $165 | 17.9% upside | |
| 2025-02-12 | NeedhamAmi Fadia | $270 | 92.9% upside | |
| 2025-02-12 | CitigroupGeoff Meacham | $160 | 14.3% upside | |
| 2024-12-09 | JefferiesMichael Yee | $180 | 28.6% upside | |
| 2024-11-15 | Robert W. BairdBrian Skorney | $300 | 114.4% upside | |
| 2024-10-31 | OppenheimerJay Olson | $255 | 82.2% upside | |
| 2024-10-31 | Morgan StanleyTerence Flynn | $204 | 45.8% upside | |
| 2024-10-30 | Raymond JamesChristopher Raymond | $315 | 125.1% upside | |
| 2024-10-30 | Goldman SachsSalveen Richter | $290 | 107.2% upside | |
| 2024-10-17 | BMO CapitalEvan Seigerman | $230 | 64.4% upside | |
| 2024-10-03 | UBSAshwani Verma | $202 | 44.3% upside | |
| 2024-09-23 | WedbushLaura Chico | $205 | 46.5% upside | |
| 2024-07-29 | Robert W. BairdBrian Skorney | $294 | 110.1% upside | |
| 2024-07-26 | Goldman SachsSalveen Richter | $342 | 144.4% upside | |
| 2024-07-26 | Piper SandlerChristopher Raymond | $307 | 119.4% upside | |
| 2024-07-26 | RBC CapitalBrian Abrahams | $282 | 101.5% upside | |
| 2024-07-12 | Piper SandlerChristopher Raymond | $313 | 123.7% upside | |
| 2024-07-11 | Morgan StanleyTerence Flynn | $311 | 122.2% upside | |
| 2024-06-12 | ScotiabankGeorge Farmer | $275 | 96.5% upside | |
| 2024-05-23 | BMO CapitalEvan David Seigerman | $260 | 85.8% upside | |
| 2024-05-22 | Stifel NicolausPaul Matteis | $275 | 96.5% upside | |
| 2024-05-22 | Raymond JamesChristopher Raymond | $335 | 139.4% upside | |
| 2024-05-22 | Morgan StanleyMatthew Harrison | $331 | 136.5% upside | |
| 2024-04-25 | WedbushLaura Chico | $215 | 53.6% upside | |
| 2024-04-25 | H.C. WainwrightAndrew Fein | $300 | 114.4% upside | |
| 2024-04-25 | RBC CapitalBrian Abrahams | $317 | 126.5% upside | |
| 2024-04-19 | OppenheimerJay Olson | $270 | 92.9% upside | |
| 2024-04-03 | BarclaysCarter Gould | $215 | 53.6% upside | |
| 2023-08-07 | WedbushLaura Chico | $269 | 92.2% upside | |
| 2023-05-01 | GuggenheimYatin Suneja | $350 | 150.1% upside | |
| 2022-12-01 | Atlantic Equities | $295 | 110.8% upside | |
| 2022-11-30 | Jefferies | $350 | 150.1% upside | |
| 2022-11-30 | Wedbush | $247 | 76.5% upside | |
| 2022-11-30 | Barclays | $313 | 123.7% upside | |
| 2022-11-15 | Truist Financial | $350 | 150.1% upside | |
| 2022-11-11 | Guggenheim | $270 | 92.9% upside | |
| 2022-09-30 | J.P. Morgan | $275 | 96.5% upside | |
| 2022-09-28 | NeedhamAmi Fadia | $250 | 78.6% upside | |
| 2022-09-28 | Morgan StanleyMatthew Harrison | $285 | 103.7% upside | |
| 2022-09-28 | Atlantic EquitiesSteve Chesney | $200 | 42.9% upside | |
| 2022-09-28 | Wedbush | $217 | 55.1% upside | |
| 2022-09-28 | Wells Fargo | $350 | 150.1% upside | |
| 2022-09-28 | RBC Capital | $321 | 129.4% upside | |
| 2022-09-28 | Piper Sandler | $280 | 100.1% upside | |
| 2022-09-28 | Mizuho SecuritiesSalim Syed | $270 | 92.9% upside | |